← Insider buys
UTHR

United Therapeutics Corporation · Healthcare

EVP and General Counsel Paul A Mahon sold $1.3M of United Therapeutics Corporation

Sold$1,254,677
$209.11Price
6,000Shares
−14%Stake

What UTHR did after the filing

Filed Jun 1Copier in Jun 2
The stock from Fri, Jun 2 open, $214.52
+10.9%
S&P 500, same days
+7.4%

Measured over 30 trading days, to the Jul 18 close.

Traded Thu, Jun 1. Filed Thu, Jun 1, 4:30 PM ET, after the close. Returns use the Jun 2 open and the Jul 18 close. Not investment advice.